Dow Up 0.76% Nasdaq Up 0.69%

Arrowhead Research Corp. (ARWR)

-NasdaqGS
7.16 Up 0.24(3.47%) Oct 24, 4:00PM EDT
|After Hours : 7.13 Down 0.03 (0.42%) Oct 24, 5:54PM EDT
Prev Close:6.92
Open:6.97
Bid:N/A
Ask:7.66 x 1300
1y Target Est:17.75
Beta:3.09
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:6.92 - 7.22
52wk Range:5.47 - 27.63
Volume:3,215,619
Avg Vol (3m):4,750,300
Market Cap:378.82M
P/E (ttm):N/A
EPS (ttm):-1.15
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ARWR

Comparison

Symbol% ChgMkt Cap
ARWRUp 3.47%378.82M
APNT 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2,092.15
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Sep-14) :-1.05
Quarterly EPS Est (Sep-14) :-0.24
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-0.90

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arrowhead Research Corporation, a biopharmaceutical company, develops targeted RNAi therapeutics in the United States. The company’s product candidate comprise ARC-520, an RNAi-based therapeutic that has completed a Phase 1 clinical trial for... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback